158 related articles for article (PubMed ID: 19672288)
1. Value of internerve tissue dissection during axillary lymphadenectomy for early breast cancer.
Rabie AS; Eldweny HI; Abdel Maksoud IG; Elbasmy AA
J Egypt Natl Canc Inst; 2007 Dec; 19(4):249-53. PubMed ID: 19672288
[TBL] [Abstract][Full Text] [Related]
2. Is dissection of the internerve tissue during axillary lymphadenectomy for breast cancer necessary?
Mostafa A; Mokbel K; Engledow A; Leris AC; Choy C; Wells C; Carpenter R
Eur J Surg Oncol; 2000 Mar; 26(2):153-4. PubMed ID: 10744934
[TBL] [Abstract][Full Text] [Related]
3. Interneural tissue clearance in axillary dissection for breast cancer: What is the importance?
Patel PK; Sinha AK; Saini S
Indian J Cancer; 2017; 54(3):539-542. PubMed ID: 29798954
[TBL] [Abstract][Full Text] [Related]
4. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
5. Is there a role for axillary dissection for patients with operable breast cancer in this era of conservatism?
Chua B; Ung O; Taylor R; Boyages J
ANZ J Surg; 2002 Nov; 72(11):786-92. PubMed ID: 12437688
[TBL] [Abstract][Full Text] [Related]
6. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
7. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
8. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
11. Axillary biopsy compared with dissection in the staging of lymph nodes in operable breast cancer. A randomised trial.
Christensen SB; Jansson C
Eur J Surg; 1993 Mar; 159(3):159-62. PubMed ID: 8102890
[TBL] [Abstract][Full Text] [Related]
12. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
13. [Presence of intramammary lymph nodes in the preoperative lymphoscintigraphy to locate the sentinel lymph node. Clinical significance].
Nogareda Z; Álvarez A; Perlaza P; Caparrós FX; Alonso I; Paredes P; Vidal-Sicart S
Rev Esp Med Nucl Imagen Mol; 2015; 34(2):83-8. PubMed ID: 25434980
[TBL] [Abstract][Full Text] [Related]
14. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection.
Nos C; Lesieur B; Clough KB; Lecuru F
Ann Surg Oncol; 2007 Sep; 14(9):2490-6. PubMed ID: 17549570
[TBL] [Abstract][Full Text] [Related]
15. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
Giuliano AE; Kirgan DM; Guenther JM; Morton DL
Ann Surg; 1994 Sep; 220(3):391-8; discussion 398-401. PubMed ID: 8092905
[TBL] [Abstract][Full Text] [Related]
16. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
18. [A new perspective on axillary dissection in situations of metastatic sentinel node].
Zedníková I; Ňaršanská A; Hes O; Metelková A; Fiala O; Svoboda T
Rozhl Chir; 2017; 96(8):346-352. PubMed ID: 29058925
[TBL] [Abstract][Full Text] [Related]
19. Association between extent of axillary lymph node dissection and patient, tumor, surgeon, and hospital factors in patients with early breast cancer.
Petrik DW; McCready DR; Sawka CA; Goel V
J Surg Oncol; 2003 Feb; 82(2):84-90. PubMed ID: 12561062
[TBL] [Abstract][Full Text] [Related]
20. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.
Avril N; Dose J; Jänicke F; Ziegler S; Römer W; Weber W; Herz M; Nathrath W; Graeff H; Schwaiger M
J Natl Cancer Inst; 1996 Sep; 88(17):1204-9. PubMed ID: 8780629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]